Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. - Wikidata - awgldk - TriplyDB

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

http://www.wikidata.org/entity/Q33882512

about

Reduced plasma membrane expression of dysferlin mutants is attributed to accelerated endocytosis via a syntaxin-4-associated pathway Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors Non-additive hepatic gene expression elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) co-treatment in C57BL/6 mice P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy Bothrops snake myotoxins induce a large efflux of ATP and potassium with spreading of cell damage and pain Influence of immune responses in gene/stem cell therapies for muscular dystrophies.IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy?The effects of MyD88 deficiency on disease phenotype in dysferlin-deficient A/J mice: role of endogenous TLR ligands.Bcl-2 inhibits the innate immune response during early pathogenesis of murine congenital muscular dystrophy Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response.Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice A new distal myopathy with mutation in anoctamin 5.The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse.CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90.Heterogeneous characteristics of Korean patients with dysferlinopathy.Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes Dysferlin and animal models for dysferlinopathy Effect of a low-protein diet supplemented with keto-acids on autophagy and inflammation in 5/6 nephrectomized rats.Chloroquine improves the response to ischemic muscle injury and increases HMGB1 after arterial ligation.Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.The potential repertoire of the innate immune system in the bladder: expression of pattern recognition receptors in the rat bladder and a rat urothelial cell line (MYP3 cells).Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders.Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane.Role of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle The inflammasomes in health and disease: from genetics to molecular mechanisms of autoinflammation and beyond Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies.Dysferlin-deficient muscular dystrophy and innate immune activation.Gut-liver axis: role of inflammasomes.Hepatitis regulation by the inflammasome signaling pathway.Immune-mediated pathology in Duchenne muscular dystrophy.Novel Mediators of Adipose Tissue and Muscle Crosstalk.Coupling of excitation to Ca2+ release is modulated by dysferlin.Serum Cytokine Profile in a Patient Diagnosed with Dysferlinopathy Progress and challenges in diagnosis of dysferlinopathy.

P2860

Q24337100-E11CE030-C5AF-47E9-8C84-BE28C7C9A462 Q26830775-BE1189BC-06A5-4E81-9A07-294824AB259A Q28069464-B2179EAB-9512-4579-A1E7-3D937C2F2AC2 Q28391958-F2DE910B-F47C-4005-A841-A1083233CB40 Q28550201-37E67063-E583-4E88-B4BB-D35B3F897975 Q30496116-0B691F38-BAFE-4DAE-9302-9FED3EB09D5B Q33736192-5C6599E0-40FC-4CA2-A715-429A89C32717 Q33799514-27046BB0-0CA7-41F2-9337-FD6FD288C693 Q33808490-3654F1FA-1D4E-4A35-8AB4-B6E54B1D2E49 Q33995531-FA135746-FD62-4F04-9C81-0882E1F9E1CC Q34103354-BCF55404-74ED-4927-BF88-08873B089BA6 Q34360151-C09AC87D-6FEF-48DA-96E3-135D14D08B7C Q34390012-4A236AF5-FD59-4CB2-86B3-FD692C38A5EF Q34483183-7B08A59F-D0C9-49CE-B034-F3E4107D03C6 Q35621283-2F3DA534-AF70-48EF-8409-F72E5B4DDE4F Q35632288-1824F94F-3315-423E-8E73-CCB7C70C3B3B Q35853255-2F544A59-1D99-4BDB-8A82-F88971304550 Q35859252-57823387-3FFA-4CFF-8C42-70331A41ED24 Q35923265-C132A32D-E712-483C-B5D1-1B7558B3E0FD Q36026239-33A85560-89A9-4054-97C5-F9474E41AE31 Q36031274-D0845630-5412-4C55-8C74-ABCB423755DE Q36085192-B1579B1B-1A79-4ED9-9A16-B9BBBD48819D Q36227351-ED21F1BE-71AD-439E-B172-D6F2BA401B87 Q36297374-9BE209DE-2C75-4DE0-AE65-AAA76BC930E9 Q36402509-7D18C174-F8F8-46F3-B06A-A43DC851BE5B Q36641513-1CFF0AE5-BE36-4EE1-8617-E103AD5399F1 Q36926351-1B2DD115-0CB7-4C26-A09B-83AA6805819D Q36971550-D281D295-24B7-4DD3-A800-8AAE711CC3F6 Q37409431-FBB36632-768F-480C-999D-1CA1470E7BAA Q37708368-1D527BF8-2681-41E4-9947-85261D0B6BC4 Q37729538-3CBEF2EC-33D6-4520-A428-D121CAC8ACF3 Q38075201-85B6F7B4-07A5-4D98-9555-B92131B44706 Q38092854-649A51C6-759C-46A8-8987-49DE227987B2 Q38371533-17BC30E9-7F8A-43BB-BAE0-CD58C0A2B6DF Q38423384-E4E0B637-541F-42C8-AC1E-9C4DCDF1F693 Q38561435-3169CB72-845D-4F53-BF9F-0363525F67E5 Q38582878-8B24F577-9C91-4C70-A259-CEE865AEF164 Q38751812-25CAF16C-AC83-4DF6-A5D1-85D5063F01F1 Q38795126-C753E3C3-1B26-4A95-AD77-EDB6EC7B35A5 Q38921880-5C7EEDF7-2266-4765-9B2E-3EC6AEE97459

P2860

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

http://www.wikidata.org/entity/Q33882512

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

@ast

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

@en

type

label

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

@ast

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

@en

prefLabel

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

@ast

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

@en

P1433

Q33882512-154D8992-D98F-443D-9382-C7393E3003AA

P1476

Q33882512-F16B4DF1-51A7-4176-979D-336443332AE8

P2093

Q33882512-0C86B02D-32A1-4D00-84D2-974A6A2A6F67

Q33882512-9AE16DBB-A136-4F58-92A1-747A10649269

Q33882512-A1FB6988-68AA-4AA5-8292-D81DBCB09760

Q33882512-AFDD24B5-6A09-4643-92FC-C69AF68A1B2E

Q33882512-C8400B2F-905E-4B80-BF19-08637CCAE420

Q33882512-F2625140-E7BB-4337-82A7-7A4677D857BC

P2860

Q33882512-037F2573-B959-4709-A5D8-C851DFE1EC05

Q33882512-0C5258D3-A1CE-4078-8BD6-E48D5F298CD4

Q33882512-113BFD7C-4B14-4F2C-A55F-DCDE6EA1F5F7

Q33882512-141442FC-CE3E-4564-9B9E-E68A6338F32A

Q33882512-24696EEA-CDB5-44C3-8631-64EC139D897F

Q33882512-2B49887E-5E86-4E28-BBDE-15DD1A06FB9B

Q33882512-3216FE9D-B3C2-47E7-B5A7-3281F1AA8F9F

Q33882512-44562E74-C784-4FD5-803D-A465225142ED

Q33882512-46F398EF-1BF4-483D-BEFC-2329F69B1DF9

Q33882512-4894EB13-7FEA-4027-BDA3-6E52CEC2EC2C

P304

Q33882512-C3630350-C30F-4B78-A30D-099EDA8C1EEF

P31

Q33882512-2CFF077F-23A9-4EC8-A0CB-BEF562C7DB37

P356

Q33882512-02FC8A8D-3260-490A-A7B4-8167444B1D31

P407

Q33882512-0413A18F-E727-4731-A1AB-0069072A9820

P433

Q33882512-BFB06C3C-8166-4B25-A693-FD5C3D7B1D52

P478

Q33882512-A45F9B8A-67F4-413D-8ACE-CAD6760B604C

P50

Q33882512-831230E2-7517-4DF4-99E2-7CAB4474397A

P577

Q33882512-062BE56A-B325-4206-8E6D-9BDFC02B2EFD

P5875

Q33882512-F0423497-C934-45ED-ABAD-EC09D247EF01

P698

Q33882512-87CC5A3D-0B65-4A0E-9F10-9212E897FCE8

P921

Q33882512-460345D4-7908-4849-B49D-49B93961FB9B

P932

Q33882512-83BEC637-D71D-4860-94F0-281DB94252C8

P356

AJPATH.2010.090058

P1433

The American Journal of Pathology

P1476

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

@en

P2093

Andrea Henriques-Pons

http://www.w3.org/2001/XMLSchema#string

Beryl Ampong

http://www.w3.org/2001/XMLSchema#string

Dwight Francia

http://www.w3.org/2001/XMLSchema#string

Eric P Hoffman

http://www.w3.org/2001/XMLSchema#string

Rashmi Rawat

http://www.w3.org/2001/XMLSchema#string

Tatiana V Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

Active caspase-1 is a regulator of unconventional protein secretion

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA

Toll-like receptors

Gout-associated uric acid crystals activate the NALP3 inflammasome

Defective membrane repair in dysferlin-deficient muscular dystrophy

Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing

Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study

P304

2891-2900

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2010.090058

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P50

Kanneboyina Nagaraju

P577

2010-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43299288

http://www.w3.org/2001/XMLSchema#string

P698

20413686

http://www.w3.org/2001/XMLSchema#string

P921

P932

2877850

http://www.w3.org/2001/XMLSchema#string